Scorpius Holdings, Inc.: M&A transaction — Scorpius Holdings' CDMO assets foreclosed Dec 10, 2025; $15.2M proceeds settle $30.2M debt

Scorpius Holdings, Inc.

Collateral agent foreclosed on substantially all non-cash assets (lab equipment $7.1M, leases, inventory) on Dec 10, 2025.
Proceeds of $15.2M applied to partially settle $30.2M secured debt; $14.9M debt remains after sale.
All CDMO employees terminated Dec 10, 2025; majority joined buyer Velocity Bioworks (Tivic Health subsidiary).
Pro forma total assets drop from $20.8M to $0.9M; accumulated deficit rises to $321.4M.
Pro forma net loss for nine months ended Sep 30, 2025 adjusted to $1.47M from $16.8M reported.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Scorpius Holdings, Inc. completed a disposition involving Velocity Bioworks, Inc., a wholly owned subsidiary of Tivic Health Systems, Inc. for $15.2 million net proceeds (closed 2025-12-10).

Action: disposition
Counterparty: Velocity Bioworks, Inc., a wholly owned subsidiary of Tivic Health Systems, Inc.
Consideration: $15.2 million net proceeds
Closing: 2025-12-10

Exact text from the filing

CDMO and research and development activities and subsidiaries, which were encumbered by the secured notes and related security agreements. The collateral agent used the $15.2 million net proceeds from the foreclosure sale to partially settle the Company’s secured debt with a balance of $30.2 million immediately prior to the December 10, 2025 closing.

View on SEC.gov

Browse all m&a transactions →

Source: SEC EDGAR

accession 0001079973-26-000283

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.